GOVX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
GOVX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Geovax Labs's accounts receivables for the quarter that ended in Mar. 2024 was $0.00 Mil.
Accounts receivable can be measured by Days Sales Outstanding.
In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Geovax Labs's Net-Net Working Capital per share for the quarter that ended in Mar. 2024 was $-1.10.
The historical data trend for Geovax Labs's Accounts Receivable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Geovax Labs Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Accounts Receivable | Get a 7-Day Free Trial | - | - | - | - | - |
Geovax Labs Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Accounts Receivable | Get a 7-Day Free Trial | - | - | - | - | - |
Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
Geovax Labs's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:
Days Sales Outstanding | |||||
= | Accounts Receivable | / | Revenue | * | Days in Period |
= | 0 | / | 0 | * | 91 |
= |
2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Geovax Labs's accounts receivable are only considered to be worth 75% of book value:
Geovax Labs's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2024 is calculated as:
Net-Net Working Capital Per Share | |||||||
= | (Cash And Cash Equivalents | + | 0.75 * Accounts Receivable | + | 0.5 * Total Inventories | - | Total Liabilities |
- | Preferred Stock | - | Minority Interest) | / | Shares Outstanding (EOP) | ||
= | (0.769 | + | 0.75 * 0 | + | 0.5 * 0 | - | 3.304 |
- | 0 | - | 0) | / | 2.30831 | ||
= | -1.10 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.
If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.
Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.
Thank you for viewing the detailed overview of Geovax Labs's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.
Mckee Kelly T. Jr. | officer: Chief Medical Officer | 233 VALLEY MEADOW DRIVE, CHAPEL HILL NC 27516 |
David A Dodd | director | C/O SEROLOGICALS CORP, 5565 SPALDING DR, NORCROSS GA 30092 |
Mark Reynolds | officer: Chief Financial Officer | TWO BALA PLAZA, SUITE 300, PHILADELPHIA PA 19004 |
Jayne Morgan | director | 1900 LAKE PARK DRIVE, SUITE 380, SMYRNA GA 30080 |
Randal D Chase | director | 28 GEORGIA COURT, RICHMOND HILL A6 L4E ON7 |
Nicole Lemerond | director | 3 MURRAY HILL ROAD, SCARSDALE NY 10583 |
John W. Sharkey | officer: VP, Business Development | 16857 E. SAGUARO BLVD., FOUNTAIN HILLS AZ 85268 |
Dean G Kollintzas | director | 1256 BRIARCLIFF ROAD N.E., EMTECH BIO SUITE 500, ATLANTA GA 30306 |
Spencer John N Jr | director | 2859 PACES FERRY RD, STE 1000, ATLANTA GA 30339 |
Robert T Mcnally | director | |
Farshad Guirakhoo | officer: Sr VP, Research & Development | 39 CHESTNUT STREET, MELROSE MA 02176 |
Steven S. Antebi | director | 10550 FONTENELLE WAY, LOS ANGELES CA 90077 |
Harriet L Robinson | other: Chair, Scientific Adv Brd | 1256 BRIARCLIFF ROAD N.E., EMTECH BIO SUITE 500, ATLANTA GA 30306 |
Mark J Newman | officer: VP, Research & Development | 1900 LAKE PARK DR, SUITE 380, SMYRNA GA 30080 |
Peter M Tsolinas | director | 123 JOAN DRIVE, BARRINGTON IL 60010 |
From GuruFocus
By sperokesalga sperokesalga • 05-24-2023
By Marketwired • 09-27-2023
By Marketwired • 09-12-2023
By Marketwired • 10-25-2023
By Marketwired • 10-05-2023
By Marketwired • 07-10-2023
By Marketwired • 10-30-2023
By Marketwired • 07-24-2023
By Marketwired • 08-28-2023
By sperokesalga sperokesalga • 05-31-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.